DiaMedica Therapeutics Stock (NASDAQ:DMAC), Quotes and News Summary

Q: What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

DiaMedica Therapeutics Stock (NASDAQ: DMAC) stock price, news, charts, stock research, profile.

Open	$2.510
Close	$2.570
Volume / Avg.	7.764K / 39.215K
Day Range	2.494 - 2.590
52 Wk Range	1.500 - 4.750
Market Cap	$96.793M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	0.85%
Days to Cover	3.39

Recent News

DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a

Nabaparna Bhattacharya

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DiaMedica Therapeutics (DMAC) stock?

You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.

View our list of the best stock brokerages.

Who are DiaMedica Therapeutics's (DMAC) competitors?

There are no as such competitors for DiaMedica Therapeutics.

What is the target price for DiaMedica Therapeutics (DMAC) stock?

The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Craig-Hallum on Wednesday, April 24, 2024. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 213.73% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for DiaMedica Therapeutics (DMAC)?

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $2.55 last updated April 25, 2024 at 6:38 PM EDT.

Does DiaMedica Therapeutics (DMAC) pay a dividend?

There are no upcoming dividends for DiaMedica Therapeutics.

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

DiaMedica Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is DiaMedica Therapeutics (DMAC) going to split?

There is no upcoming split for DiaMedica Therapeutics.

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.